SUPN
Supernus Pharmaceuticals Inc
42.80$
+0.9%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 35.0% | 38.6% | 41.7% | 44.9% | 47.7% | 50.1% | 51.0% | 53.4% | 41.8% | 44.3% | 48.7% | 50.7% | |
| 7.4% | 5.9% | 4.9% | 4.0% | 2.4% | 5.1% | 8.6% | 10.5% | 10.7% | 8.8% | 12.3% | 12.6% | |
| 15.6% | 19.9% | 22.8% | 26.4% | 30.0% | 33.2% | 34.4% | 37.8% | 19.8% | 21.2% | 25.6% | 26.1% | |
| 11.0% | 11.3% | 11.3% | 11.6% | 10.8% | 10.4% | 10.8% | 10.2% | 12.1% | 12.9% | 12.1% | 14.8% | |
| 6.5% | 6.1% | 5.8% | 5.2% | 4.8% | 4.0% | 3.7% | 3.2% | 5.6% | 5.7% | 5.8% | 5.9% | |
| 9.1% | 9.2% | 9.0% | 8.9% | 8.7% | 8.6% | 8.7% | 8.5% | 8.4% | 8.6% | 8.0% | 8.4% | |
| 49.9% | 47.0% | 44.5% | 42.5% | 40.2% | 38.1% | 37.3% | 34.8% | 43.9% | 39.2% | 36.6% | 32.9% | |
| 29.0% | 27.9% | 28.7% | 27.2% | 25.0% | 24.3% | 23.5% | 23.0% | 26.1% | 26.9% | 28.2% | 27.8% | |
| 22.4% | 22.7% | 24.1% | 23.5% | 21.7% | 21.4% | 20.9% | 20.7% | 23.3% | 23.3% | 24.9% | 24.3% | |
| 0.7% | 0.7% | 0.7% | 0.7% | 0.7% | 0.5% | 0.4% | 0.5% | 0.8% | 0.7% | 0.7% | 0.8% | |
| 0.3% | 0.2% | 1.1% | 0.4% | 0.5% | 0.3% | 0.5% | 0.6% | 0.6% | 0.2% | 0.7% | 0.4% | |
| 71.0% | 72.1% | 71.3% | 72.8% | 75.0% | 75.7% | 76.5% | 77.0% | 73.9% | 73.1% | 71.8% | 72.2% | |
| 37.5% | 37.8% | 37.0% | 38.2% | 40.3% | 40.7% | 40.4% | 41.0% | 36.8% | 35.7% | 34.4% | 32.0% | |
| 4.2% | 4.3% | 4.3% | 4.2% | 4.2% | 4.1% | 4.1% | 4.1% | 4.0% | 3.9% | 3.8% | 4.1% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.